{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:53:05Z","timestamp":1790837585401,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":1604,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI11\/00678"],"award-info":[{"award-number":["PI11\/00678"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007136","name":"Secretar?a de Estado de Investigaci?n, Desarrollo e Innovaci?n","doi-asserted-by":"publisher","award":["SAF2015-66625-R"],"award-info":[{"award-number":["SAF2015-66625-R"]}],"id":[{"id":"10.13039\/501100007136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEOII\/2014\/067"],"award-info":[{"award-number":["PROMETEOII\/2014\/067"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEOII\/2014\/029"],"award-info":[{"award-number":["PROMETEOII\/2014\/029"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["ACIF\/2014\/090"],"award-info":[{"award-number":["ACIF\/2014\/090"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["ACOMP\/2014\/058"],"award-info":[{"award-number":["ACOMP\/2014\/058"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci?n Ram?n Areces","doi-asserted-by":"publisher","award":["CIVP18A3899"],"award-info":[{"award-number":["CIVP18A3899"]}],"id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s13311-018-00706-z","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T14:15:59Z","timestamp":1550067359000},"page":"432-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model"],"prefix":"10.1016","volume":"16","author":[{"given":"Bel\u00e9n","family":"Moll\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana C.","family":"Mu\u00f1oz-Lasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Calap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Fernandez-Vilata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"de la Iglesia-Vaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico V.","family":"Pallard\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dolores","family":"Molt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Palau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3131-6334","authenticated-orcid":false,"given":"Pilar","family":"Gonzalez-Cabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1007\/s13311-018-00706-z_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-010-0675-0","article-title":"Pathology and pathogenesis of sensory neuropathy in Friedreich's ataxia","volume":"120","author":"Morral","year":"2010","journal-title":"Acta neuropathologica."},{"issue":"2","key":"10.1007\/s13311-018-00706-z_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/NEN.0b013e31827e5762","article-title":"Friedreich ataxia: neuropathology revised","volume":"72","author":"Koeppen","year":"2013","journal-title":"J Neuropathol Exp Neurol."},{"issue":"1\u20132","key":"10.1007\/s13311-018-00706-z_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","article-title":"Friedreich's ataxia: pathology, pathogenesis, and molecular genetics","volume":"303","author":"Koeppen","year":"2011","journal-title":"J Neurol Sci."},{"key":"10.1007\/s13311-018-00706-z_bib4","doi-asserted-by":"crossref","unstructured":"Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science (New York NY). 1996;271(5254):1423\u20137.","DOI":"10.1126\/science.271.5254.1423"},{"issue":"4","key":"10.1007\/s13311-018-00706-z_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng0497-337","article-title":"Frataxin fracas","volume":"15","author":"Cossee","year":"1997","journal-title":"Nat Genet."},{"key":"10.1007\/s13311-018-00706-z_bib6","doi-asserted-by":"crossref","unstructured":"Vaubel RA, Isaya G. Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia. Molecular and Cellular Neurosciences. 2012. https:\/\/doi.org\/10.1016\/j.mcn.2012.08.003.","DOI":"10.1016\/j.mcn.2012.08.003"},{"issue":"11","key":"10.1007\/s13311-018-00706-z_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1042\/CS20160072","article-title":"Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia","volume":"130","author":"Chiang","year":"2016","journal-title":"Clinical Science."},{"issue":"22","key":"10.1007\/s13311-018-00706-z_bib8","doi-asserted-by":"crossref","first-page":"12239","DOI":"10.1073\/pnas.220403797","article-title":"Frataxin activates mitochondrial energy conversion and oxidative phosphorylation","volume":"97","author":"Ristow","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1\u20132","key":"10.1007\/s13311-018-00706-z_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jns.2005.03.012","article-title":"Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia","volume":"233","author":"Calabrese","year":"2005","journal-title":"J Neurol Sci."},{"issue":"20","key":"10.1007\/s13311-018-00706-z_bib10","doi-asserted-by":"crossref","first-page":"11492","DOI":"10.1073\/pnas.96.20.11492","article-title":"Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia","volume":"96","author":"Lodi","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1007\/s13311-018-00706-z_bib11","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.55.11.1752","article-title":"Increased levels of plasma malondialdehyde in Friedreich ataxia","volume":"55","author":"Emond","year":"2000","journal-title":"Neurology."},{"issue":"11","key":"10.1007\/s13311-018-00706-z_bib12","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1212\/WNL.55.11.1719","article-title":"Oxidative stress in patients with Friedreich ataxia","volume":"55","author":"Schulz","year":"2000","journal-title":"Neurology."},{"issue":"3","key":"10.1007\/s13311-018-00706-z_bib13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1023\/B:NERE.0000014826.00881.c3","article-title":"Role of oxidative damage in Friedreich's ataxia","volume":"29","author":"Bradley","year":"2004","journal-title":"Neurochem Res."},{"key":"10.1007\/s13311-018-00706-z_bib14","first-page":"124","article-title":"Mitochondrial dysfunction induced by frataxin deficiency is associated with cellular senescence and abnormal calcium metabolism","volume":"8","author":"Bolinches-Amoros","year":"2014","journal-title":"Frontiers in cellular neuroscience."},{"issue":"4","key":"10.1007\/s13311-018-00706-z_bib15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1017\/S0317167100022927","article-title":"The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases","volume":"7","author":"Lamarche","year":"1980","journal-title":"Can J Neurol Sci."},{"issue":"2","key":"10.1007\/s13311-018-00706-z_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1097-215","article-title":"Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia","volume":"17","author":"Rotig","year":"1997","journal-title":"Nat Genet."},{"key":"10.1007\/s13311-018-00706-z_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.gene.2005.04.040","article-title":"Increased IRP1 activity in Friedreich ataxia","volume":"354","author":"Lobmayr","year":"2005","journal-title":"Gene."},{"issue":"4","key":"10.1007\/s13311-018-00706-z_bib18","doi-asserted-by":"crossref","first-page":"e94069","DOI":"10.1371\/journal.pone.0094069","article-title":"Gene expression profiling of mitochondrial oxidative phosphorylation (OXPHOS) complex I in Friedreich ataxia (FRDA) patients","volume":"9","author":"Salehi","year":"2014","journal-title":"PLoS ONE."},{"issue":"15","key":"10.1007\/s13311-018-00706-z_bib19","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/hmg\/ddi214","article-title":"Frataxin interacts functionally with mitochondrial electron transport chain proteins","volume":"14","author":"Gonzalez-Cabo","year":"2005","journal-title":"Hum Mol Genet."},{"key":"10.1007\/s13311-018-00706-z_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fphar.2014.00029","article-title":"Mitochondrial iron-sulfur cluster dysfunction in neurodegenerative disease","volume":"5","author":"Isaya","year":"2014","journal-title":"Frontiers in Pharmacology."},{"key":"10.1007\/s13311-018-00706-z_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-90-481-2813-6_17","article-title":"Friedreich ataxia: an update on animal models, frataxin function and therapies","volume":"652","author":"Gonzalez-Cabo","year":"2009","journal-title":"Adv Exp Med Biol."},{"issue":"5","key":"10.1007\/s13311-018-00706-z_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neurol.2014.03.008","article-title":"Pathophysiogical and therapeutic progress in Friedreich ataxia","volume":"170","author":"Puccio","year":"2014","journal-title":"Revue neurologique."},{"issue":"1","key":"10.1007\/s13311-018-00706-z_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/nmt.15.73","article-title":"Emerging therapies in Friedreich's ataxia","volume":"6","author":"Aranca","year":"2016","journal-title":"Neurodegenerative Disease Management."},{"key":"10.1007\/s13311-018-00706-z_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40673-017-0062-x","article-title":"Friedreich ataxia: current status and future prospects","volume":"4","author":"Burk","year":"2017","journal-title":"Cerebellum & Ataxias."},{"issue":"9","key":"10.1007\/s13311-018-00706-z_bib25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/14737175.2017.1356721","article-title":"Pharmacological therapeutics in Friedreich ataxia: the present state","volume":"17","author":"Strawser","year":"2017","journal-title":"Expert Review of Neurotherapeutics."},{"issue":"5","key":"10.1007\/s13311-018-00706-z_bib26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ygeno.2006.06.015","article-title":"GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology","volume":"88","author":"Al-Mahdawi","year":"2006","journal-title":"Genomics."},{"key":"10.1007\/s13311-018-00706-z_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fnmol.2017.00264","article-title":"Reversible axonal dystrophy by calcium modulation in frataxin-deficient sensory neurons of YG8R mice","volume":"10","author":"Molla","year":"2017","journal-title":"Frontiers in Molecular Neuroscience."},{"issue":"34","key":"10.1007\/s13311-018-00706-z_bib28","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.2174\/092986712804143286","article-title":"Interactions between calcium and cAMP signaling","volume":"19","author":"Hofer","year":"2012","journal-title":"Curr Med Chem."},{"issue":"6","key":"10.1007\/s13311-018-00706-z_bib29","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.cmet.2013.05.003","article-title":"Mitochondrial Ca(2)(+) uptake induces cyclic AMP generation in the matrix and modulates organelle ATP levels","volume":"17","author":"Di Benedetto","year":"2013","journal-title":"Cell Metab."},{"key":"10.1007\/s13311-018-00706-z_bib30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fncel.2014.00376","article-title":"Intermingled cAMP, cGMP and calcium spatiotemporal dynamics in developing neuronal circuits","volume":"8","author":"Averaimo","year":"2014","journal-title":"Frontiers in Cellular Neuroscience."},{"issue":"18","key":"10.1007\/s13311-018-00706-z_bib31","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1111\/j.1742-4658.2009.07228.x","article-title":"Ca2+\/calmodulin-dependent kinase II signalling cascade mediates P2X7 receptor-dependent inhibition of neuritogenesis in neuroblastoma cells","volume":"276","author":"Gomez-Villafuertes","year":"2009","journal-title":"The FEBS Journal."},{"issue":"Pt 1","key":"10.1007\/s13311-018-00706-z_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1242\/jcs.091736","article-title":"Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation","volume":"125","author":"del Puerto","year":"2012","journal-title":"J Cell Sci."},{"issue":"33","key":"10.1007\/s13311-018-00706-z_bib33","doi-asserted-by":"crossref","first-page":"13776","DOI":"10.1073\/pnas.1100247108","article-title":"Spatial and temporal second messenger codes for growth cone turning","volume":"108","author":"Nicol","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"14","key":"10.1007\/s13311-018-00706-z_bib34","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.febslet.2015.05.007","article-title":"Regulation of neuronal communication by G protein-coupled receptors","volume":"589","author":"Huang","year":"2015","journal-title":"FEBS letters."},{"issue":"14","key":"10.1007\/s13311-018-00706-z_bib35","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1523\/JNEUROSCI.3650-14.2015","volume":"35","author":"Fukuchi","year":"2015","journal-title":"The Journal of Neuroscience: the official journal of the Society for Neuroscience"},{"issue":"13","key":"10.1007\/s13311-018-00706-z_bib36","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1523\/JNEUROSCI.21-13-04731.2001","article-title":"Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate","volume":"21","author":"Cai","year":"2001","journal-title":"J Neurosci."},{"issue":"11","key":"10.1007\/s13311-018-00706-z_bib37","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1161\/01.STR.0000034399.95249.59","article-title":"Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats","volume":"33","author":"Zhang","year":"2002","journal-title":"Stroke."},{"issue":"4","key":"10.1007\/s13311-018-00706-z_bib38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.STR.0000158923.19956.73","article-title":"Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor","volume":"36","author":"Zhang","year":"2005","journal-title":"Stroke."},{"key":"10.1007\/s13311-018-00706-z_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.pharmtox.41.1.145","article-title":"Regulation and role of adenylyl cyclase isoforms","volume":"41","author":"Hanoune","year":"2001","journal-title":"Annual Review of Pharmacology and Toxicology."},{"issue":"4","key":"10.1007\/s13311-018-00706-z_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1447-073x.2004.00089.x","article-title":"Involvement of cAMP in neuronal survival and axonal regeneration","volume":"79","author":"Cui","year":"2004","journal-title":"Anatomical Science International."},{"issue":"3","key":"10.1007\/s13311-018-00706-z_bib41","first-page":"225","article-title":"A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia","volume":"8","author":"Anjomani Virmouni","year":"2015","journal-title":"Dis Model Mech."},{"issue":"6","key":"10.1007\/s13311-018-00706-z_bib42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1242\/dmm.024273","article-title":"Two different pathogenic mechanisms, dying-back axonal neuropathy and pancreatic senescence, are present in the YG8R mouse model of Friedreich's ataxia","volume":"9","author":"Molla","year":"2016","journal-title":"Dis Model Mech."},{"issue":"4","key":"10.1007\/s13311-018-00706-z_bib43","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0306-4522(96)00465-4","article-title":"Neurotransmitter release from growth cones of rat dorsal root ganglion neurons in culture","volume":"77","author":"Soeda","year":"1997","journal-title":"Neuroscience."},{"key":"10.1007\/s13311-018-00706-z_bib44","doi-asserted-by":"crossref","unstructured":"Nikulina E, Tidwell JL, Dai HN, Bregman BS, Filbin MT. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(23):8786\u201390. https:\/\/doi.org\/10.1073\/pnas.0402595101.","DOI":"10.1073\/pnas.0402595101"},{"key":"10.1007\/s13311-018-00706-z_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroscience.2016.05.005","article-title":"MicroRNA 146a locally mediates distal axonal growth of dorsal root ganglia neurons under high glucose and sildenafil conditions","volume":"329","author":"Jia","year":"2016","journal-title":"Neuroscience."},{"key":"10.1007\/s13311-018-00706-z_bib46","doi-asserted-by":"crossref","first-page":"e2237","DOI":"10.1038\/cddis.2016.111","article-title":"Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia","volume":"7","author":"Abeti","year":"2016","journal-title":"Cell Death & Disease."},{"issue":"13","key":"10.1007\/s13311-018-00706-z_bib47","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1089\/ars.2012.4537","article-title":"Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model","volume":"19","author":"Shan","year":"2013","journal-title":"Antioxidants & Redox Signaling."},{"issue":"Suppl 1","key":"10.1007\/s13311-018-00706-z_bib48","first-page":"S252","article-title":"Phosphodiesterase inhibitors","volume":"147","author":"Boswell-Smith","year":"2006","journal-title":"British Journal of Pharmacology."},{"issue":"2","key":"10.1007\/s13311-018-00706-z_bib49","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1471-4159.1997.69020845.x","article-title":"Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists","volume":"69","author":"Sharma","year":"1997","journal-title":"J Neurochem."},{"issue":"5","key":"10.1007\/s13311-018-00706-z_bib50","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s00415-015-7719-2","article-title":"An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels","volume":"262","author":"Yiu","year":"2015","journal-title":"J Neurol."},{"issue":"2","key":"10.1007\/s13311-018-00706-z_bib51","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.mito.2010.12.003","article-title":"Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function","volume":"11","author":"Selak","year":"2011","journal-title":"Mitochondrion."},{"issue":"8","key":"10.1007\/s13311-018-00706-z_bib52","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/pmic.200701049","article-title":"Proteomic analysis of hearts from frataxin knockout mice: marked rearrangement of energy metabolism, a response to cellular stress and altered expression of proteins involved in cell structure, motility and metabolism","volume":"8","author":"Sutak","year":"2008","journal-title":"Proteomics."},{"issue":"4 Pt A","key":"10.1007\/s13311-018-00706-z_bib53","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bbadis.2018.01.010","article-title":"Quantitative proteomics in Friedreich's ataxia B-lymphocytes: a valuable approach to decipher the biochemical events responsible for pathogenesis","volume":"1864","author":"Telot","year":"2018","journal-title":"Biochimica et biophysica acta Molecular Basis of Disease"},{"issue":"11","key":"10.1007\/s13311-018-00706-z_bib54","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/jnr.23262","article-title":"Quantitative profiling and identification of differentially expressed plasma proteins in Friedreich's ataxia","volume":"91","author":"Swarup","year":"2013","journal-title":"J Neurosci Res."},{"issue":"6710","key":"10.1007\/s13311-018-00706-z_bib55","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/24884","article-title":"Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP","volume":"396","author":"de Rooij","year":"1998","journal-title":"Nature."},{"issue":"32","key":"10.1007\/s13311-018-00706-z_bib56","doi-asserted-by":"crossref","first-page":"11315","DOI":"10.1523\/JNEUROSCI.3645-14.2015","article-title":"Exchange protein directly activated by cAMP (EPAC) regulates neuronal polarization through Rap1B","volume":"35","author":"Munoz-Llancao","year":"2015","journal-title":"The Journal of Neuroscience: the official journal of the Society for Neuroscience."},{"issue":"1\u20132","key":"10.1007\/s13311-018-00706-z_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/NMM:7:1-2:003","article-title":"Class II G protein-coupled receptors and their ligands in neuronal function and protection","volume":"7","author":"Martin","year":"2005","journal-title":"Neuromolecular Med."},{"issue":"3","key":"10.1007\/s13311-018-00706-z_bib58","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.freeradbiomed.2010.04.031","article-title":"The purinergic P2Y(13) receptor activates the Nrf2\/HO-1 axis and protects against oxidative stress-induced neuronal death","volume":"49","author":"Espada","year":"2010","journal-title":"Free Radical Biology & Medicine."},{"key":"10.1007\/s13311-018-00706-z_bib59","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.2741\/3022","article-title":"Regulation of neurite outgrowth by G(i\/o) signaling pathways","volume":"13","author":"Bromberg","year":"2008","journal-title":"Frontiers in Bioscience: a journal and virtual library."},{"issue":"4","key":"10.1007\/s13311-018-00706-z_bib60","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nature Reviews Drug Discovery."},{"issue":"2","key":"10.1007\/s13311-018-00706-z_bib61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.expneurol.2007.06.020","article-title":"The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury","volume":"209","author":"Hannila","year":"2008","journal-title":"Experimental Neurology."},{"issue":"11","key":"10.1007\/s13311-018-00706-z_bib62","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1172\/JCI22831","article-title":"Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment","volume":"114","author":"Gong","year":"2004","journal-title":"J Clin Invest."},{"key":"10.1007\/s13311-018-00706-z_bib63","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuroscience.2011.07.039","article-title":"Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice","volume":"193","author":"Wang","year":"2011","journal-title":"Neuroscience."},{"issue":"14","key":"10.1007\/s13311-018-00706-z_bib64","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1093\/hmg\/ddx141","article-title":"Frataxin deficiency impairs mitochondrial biogenesis in cells, mice and humans","volume":"26","author":"Jasoliya","year":"2017","journal-title":"Human Molecular Genetics."},{"issue":"11","key":"10.1007\/s13311-018-00706-z_bib65","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1242\/dmm.030502","article-title":"Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia","volume":"10","author":"Lin","year":"2017","journal-title":"Disease Models & Mechanisms."},{"key":"10.1007\/s13311-018-00706-z_bib66","doi-asserted-by":"crossref","unstructured":"Palandri A, Martin E, Russi M, Rera M, Tricoire H, Monnier V. Identification of cardioprotective drugs by medium-scale in vivo pharmacological screening on a Drosophila cardiac model of Friedreich's ataxia. Disease Models & Mechanisms. 2018;11(7). https:\/\/doi.org\/10.1242\/dmm.033811.","DOI":"10.1242\/dmm.033811"},{"key":"10.1007\/s13311-018-00706-z_bib67","doi-asserted-by":"crossref","unstructured":"Igoillo-Esteve M, Gurgul-Convey E, Hu A, Romagueira Bichara Dos Santos L, Abdulkarim B, Chintawar S et al. Unveiling a common mechanism of apoptosis in beta-cells and neurons in Friedreich's ataxia. Human Molecular Genetics. 2015;24(8):2274\u201386. https:\/\/doi.org\/10.1093\/hmg\/ddu745.","DOI":"10.1093\/hmg\/ddu745"},{"issue":"2","key":"10.1007\/s13311-018-00706-z_bib68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1096\/fasebj.7.2.7680013","article-title":"Intracellular cyclic GMP receptor proteins","volume":"7","author":"Lincoln","year":"1993","journal-title":"FASEB Journal: official publication of the Federation of American Societies for Experimental Biology."},{"issue":"6","key":"10.1007\/s13311-018-00706-z_bib69","first-page":"923","article-title":"Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells","volume":"40","author":"Cornwell","year":"1991","journal-title":"Molecular Pharmacology."},{"issue":"1","key":"10.1007\/s13311-018-00706-z_bib70","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/jpet.113.210708","article-title":"BK channel-mediated relaxation of urinary bladder smooth muscle: a novel paradigm for phosphodiesterase type 4 regulation of bladder function","volume":"349","author":"Xin","year":"2014","journal-title":"The Journal of Pharmacology and Experimental Therapeutics."},{"key":"10.1007\/s13311-018-00706-z_bib71","doi-asserted-by":"crossref","first-page":"e2198","DOI":"10.1038\/cddis.2016.106","article-title":"A cardiac mitochondrial cAMP signaling pathway regulates calcium accumulation, permeability transition and cell death","volume":"7","author":"Wang","year":"2016","journal-title":"Cell Death & Disease."},{"issue":"3","key":"10.1007\/s13311-018-00706-z_bib72","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cmet.2009.01.012","article-title":"Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation","volume":"9","author":"Acin-Perez","year":"2009","journal-title":"Cell Metabolism."},{"issue":"35","key":"10.1007\/s13311-018-00706-z_bib73","doi-asserted-by":"crossref","first-page":"30423","DOI":"10.1074\/jbc.M111.266379","article-title":"A phosphodiesterase 2A isoform localized to mitochondria regulates respiration","volume":"286","author":"Acin-Perez","year":"2011","journal-title":"J Biol Chem."},{"issue":"2","key":"10.1007\/s13311-018-00706-z_bib74","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1113\/jphysiol.2013.259135","article-title":"Ca2+ and cAMP cross-talk in mitochondria","volume":"592","author":"Di Benedetto","year":"2014","journal-title":"The Journal of Physiology."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-018-00706-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-00706-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923018871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923018871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-00706-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:12:33Z","timestamp":1761808353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923018871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1878747923018871"],"URL":"https:\/\/doi.org\/10.1007\/s13311-018-00706-z","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-018-00706-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}